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The association of the tuberous sclerosis complex with angiomyolipoma (AML) arising from the retro-
peritoneum and mediastinum has not been reported in the literature. We present the ﬁrst case in which
a patient presented with a combined retroperitoneal extrarenal and posterior mediastinal AML. Inter-
estingly, the ipsilateral retroperitoneal AML emerged 15 years after radical nephrectomy for the left renal
AML.
Copyright  2014, Taiwan Urological Association. Published by Elsevier Taiwan LLC.1. Introduction
Angiomyolipomas (AMLs) are benign tumors characterized by
three major histological components, namely, blood vessels,
smooth muscle, and fat. Extrarenal retroperitoneal AMLs are rare
and difﬁcult to differentiate from lipomas and liposarcomas pre-
operatively because they share common fatty components.1
The tuberous sclerosis complex (TSC) is reported to have an
association with AMLs in the kidney and liver and pulmonary
lymphangioleiomyomatosis (LAM). We report herein a case in
which a TSC patient had extrarenal retroperitoneal AML that
extended into the mediastinum. Previous studies have not
mentioned the importance of postoperative follow up, and there-
fore, this critical activity is also emphasized in the present report.ogy, Kaohsiung Municipal
Xiaogang District, Kaohsiung
@msa.hinet.net (J.-T. Shen).
ciation. Published by Elsevier Taiw2. Case report
A 45-year-old female with a medical history of TSC (mental
retardation, seizure, and left renal AML diagnosed 15 years after
radical nephrectomy) presented to our emergency department
with poor appetite, vomiting, abdominal pain, and constipation.
Fifteen years previously, she underwent a left radical nephrectomy
with preoperative embolization of the renal artery owing to the
presence of a huge left renal AML squeezing on the descending
colon in the right side of the abdomen, causing poor appetite and
constipation. The pathology report revealed classic AML without
renal vessel invasion. Upon admission (15 years later), a physical
examination revealed a huge painless palpable mass with elastic to
ﬁrm consistency and adenoma sebaceum skin lesions in the malar
region of her face, but there were unremarkable urinalysis and
blood biochemical ﬁndings.
An abdominal computed tomography (CT) scan upon admission
revealed an adhesion ileus, left giant retroperitoneal tumor
extending over the right retroperitoneum, and multifocal lip-
omatosis involving the posterior mediastinum, right kidney, and
liver (Fig.1). The CTalso showedmultiple pulmonary nodules in thean LLC. Open access under CC BY-NC-ND license.
Fig. 1. Contrast axial computed tomography (CT) scan image showing (A) bilateral exuberant fat containing inﬁltrating tumor involving the entire retroperitoneum (arrow) and
surrounding the right kidney (arrowheads), (B) with an upward extension into the posterior mediastinum in the thoracic cavity (arrow). (C) Coronal reconstruction CT image
correlating a retroperitoneal lipomatous tumor with descending colon displacement, characteristic enlarged right renal angiomyolipoma fat inﬁltration (arrow), and mediastinum
extension features (arrowhead).
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pneumothorax at the pericardial region. The AMLs of the right
kidney and left retroperitoneum were highly suspected based on
radiologic characteristics and the history of concurrent TSC and
AML, but liposarcomas cannot be totally excluded. A direct exten-
sion from the retroperitoneal AML to the posterior mediastinum is
depicted in Fig. 1C. The patient was transferred to the urologic
department for surgery because malignancy could not be ruled out.
A concomitant thoracotomy for the suspectedmediastinal AMLwas
postponed by the chest surgeon due to the absence of chest
symptoms. Laparotomy was performed through a left paramedian
incision. A previous operation made the operative plane adhesive
to the adjacent great vessels. A brown to yellowish tumor with a
ﬁbrotic capsule and tortuous vessels was found to occupy the
whole left retroperitoneum. The right kidney was left intact to
provide a surgical plane and because of the fear of renal failure. The
pathological examination showed that the tumor was composed of
mature adipose tissue, large blood vessels with thick muscular
walls, and some foci showing epithelioid cells surrounding the
vessels, all of which are consistent with classic AML (Fig. 2). The
patient’s postoperative recovery was uneventful and she was dis-
charged on the 11th postoperative day. The patient was free from
gastrointestinal symptoms at the 12-month follow-up
examination.
3. Discussion
TSC, an autosomal dominant disorder, has concomitant benign
tumors involving various organs including the kidney (AMLs and
cysts), brain (subependymal giant cell astrocytomas and elipto-
genic tubers), skin (facial angioﬁbromas), lung (LAM), heart
(rhabdomyomas), and retina. Most AMLs (approximately 70e80%)were sporadic, but the remainder (approximately 20e30%) were
related to TSC. By contrast, 80% of patients with TSC and nearly 50%
of patients with LAM have associated renal AMLs.2,3 Although
benign in nature, all TSC tumors have the potential to cause organ
failure or could become life threatening. Rupture of the renal AML is
disastrous and brain lesions may be associated with seizures,
mental retardation, and autism.
In contrast to renal AMLs, extrarenal AMLs are very rare and
considered to be a reﬂection of multicentricity.4 The liver and
uterus appear to be the most common locations of this condition,
but it has been reported at other sites as well, including the bone,
colon, heart, lung, parotid gland, skin, spermatic cord, and retro-
peritoneum (retroperitoneal extrarenal AMLs are extremely rare).
There is a wide age distribution in these cases (28e73 years), and
more females than males develop such conditions.
No reports have related retroperitoneal AMLs progression to
malignant neoplasms except for epithelioid AMLs, which are
composed exclusively or predominantly of epithelioid components.
The symptoms of retroperitoneal AML are nonspeciﬁc and associ-
ated with gastrointestinal symptoms (e.g., nausea, vomiting, con-
stipation, and abdominal distension) that are related to the
presence of the retroperitoneal tumor mass. We do not yet know
the deﬁnite mechanism of recurrence, but multicentricity or peri-
vascular epithelioid tumor cells, including AML and LAM, possess-
ing the potential to migrate or metastasize along vessels or
lymphatic chains in vivo are hypothesized to induce recurrence.5
Many radiologic characteristics for diagnosing classic AML have
been reported. Simpson and Patel6 recommended that CT scans use
a line of four pixels at no more than 10 Hounsﬁeld units (HU) or a
square of four pixels with no more than 10 HU as the discrimi-
nating thresholds. Davenport et al7 proposed an attenuation
threshold of 10 HU or lower with a region of interest of at least
Fig. 2. Histological feature. (A) Tumor showing thick-walled, tortuous vessels with surrounding smooth muscle cells embedded in mature adipose tissue (hematoxylin and eosin,
40). (B) The tumor cells were positive for HMB-45 immunostain (100).
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signal intensity on non-enhanced T1-weighted images and T2-
weighted images is characteristic of AMLs. Regardless of whether
CT or magnetic resonance imaging was performed, AMLs were well
circumscribed and their vascular components appeared to be well
enhanced on both types of scans. However, the radiologic features
of retroperitoneal and mediastinal AML are very hard to differen-
tiate from other fatty tumors such as liposarcomas, lipomas, and
leiomyomas with fatty changes. The deﬁnitive diagnoses of retro-
peritoneal and mediastinal AML are dependent on histopatholog-
ical analyses.
Like retroperitoneal AMLs, mediastinal AMLs are very rare dis-
eases, and only a few case reports were found.8e16 Among these,
females predominate and age distribution is wide (22e72 years).
Tumors were equally distributed in the anterior, middle, and pos-
terior mediastinum. Although there were multiple pulmonary
nodules in the present case as well as in other reported cases, the
involvement of the lymph node and organs other than kidneys
suggests multicentricity rather than metastasis.17,18
TSC is an autosomal dominant syndrome resulting from losses of
TSC1 (9q34) or TSC2 (16p13.3). The major role of TSC1 and TSC2
gene products, hamartin and the tuberin complex, is to inhibit the
mammalian target of rapamycin (mTOR), a central regulator of cell
growth.19 In patients with TSC-related AMLs, there is a newer
systemic treatment option that directly targets mTOR to treat the
underlying course of TSC.20 Recently, a randomized, placebo-
controlled Phase III trial on everolimus21 (n ¼ 118) showed that
42% of the patients on everolimus experienced a response
compared with 0% patients on placebo, based on best overall
response rate. They also found that the time to AML progression
was signiﬁcantly longer in the patients on everolimus.21 Ever-
olimus, which inhibits mTOR activity in its signaling pathway, may
reduce cell proliferation and blood vessel growth related to AML
associated with TSC.22 Neoadjuvant treatment withmTOR inhibitor
for tumor size reduction prior to the operation may be a valid
option.In conclusion, although an excellent outcome and nearly 100%
recovery has been proposed to occur after the complete excision of
classic renal AMLs,23 ipsilateral retroperitoneal extrarenal AMLs
may emerge even after a relatively long-term follow up. By
contrast, TSC is associated with AML in the kidney and liver, but
retroperitoneal extrarenal AMLs and mediastinal AMLs (although
with no histopathological proof) have never been reported in pa-
tients with TSC prior to now. We present herein the ﬁrst case of
retroperitoneal extrarenal AMLs in a patient with TSC, and it is also
the ﬁrst reported case of concomitant posterior mediastinal AML in
a patient with TSC. A postoperative long-term follow up is therefore
very important in patients with TSC.Conﬂicts of interest
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